Vycor Medical, Inc. (VYCO)

OTCMKTS · Delayed Price · Currency is USD

0.0690

-0.0010 (-1.43%)

Apr 28, 2026, 4:00 PM EST

1.62% (1Y)

Market Cap	2.30M
Revenue (ttm)	1.86M
Net Income (ttm)	-396.80K
Shares Out	33.42M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,000
Average Volume	22,506
Open	0.0511
Previous Close	0.0700
Day's Range	0.0511 - 0.0700
52-Week Range	0.0321 - 0.5000
Beta	-0.41
RSI	37.82
Earnings Date	May 12, 2026

About Vycor Medical

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2005

Employees 7

Stock Exchange OTCMKTS

Ticker Symbol VYCO

Full Company Profile

Financial Performance

In 2025, Vycor Medical's revenue was $1.86 million, an increase of 17.24% compared to the previous year's $1.59 million. Losses were -$396,796, -8.06% less than in 2024.

Financial Statements

News

There is no news available yet.